Kiniksa Pharmaceuticals Chief Accounting Officer Michael R. Megna Sells $3.42 Million in Common Shares

Bitget2026/11/03 23:26

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Kiniksa Pharmaceuticals International Chief Accounting Officer Michael R. Megna sold 36,260 Class A Ordinary Shares on October 30, 2026.
Reported sale prices ranged from $91.87 to $97.74 per share.
Megna also exercised options for 19,895 Class A Ordinary Shares at exercise prices ranging from $10.76 to $17.76.
Following the transactions, he directly owned 12,697 Class A Ordinary Shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001464583-26-000010), on November 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Kiniksa Pharmaceuticals Chief Accounting Officer Michael R. Megna Sells $3.42 Million in Common Shares

You may also like

Crypto prices